SCHEMBL29623391

SCHEMBL29623391

COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC1CCCOC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.73
EPHB4 P54760 5/20 0.73
ERBB2 P04626 4/20 0.73
EPHA2 P29317 3/20 0.73
EGFR P00533 16/20 0.72
FLT4 P35916 2/20 0.69
AURKA O14965 1/20 0.69
INSR P06213 1/20 0.69
FBP1 P09467 1/20 0.69
PDGFRB P09619 1/20 0.69
CLK1 P49759 1/20 0.69
TEK Q02763 1/20 0.69
AURKB Q96GD4 1/20 0.69
CIT O14578 1/20 0.61
GAK O14976 1/20 0.61
EPHB6 O15197 1/20 0.61
ABCC4 O15439 1/20 0.61
DAPK3 O43293 1/20 0.61
RIPK2 O43353 1/20 0.61
NR1I2 O75469 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL120714 1.00 KDR (0.73) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL2704818 1.00 KDR (0.73) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL13606795 0.96 EGFR (0.69) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL1446388 0.95 KDR (0.81) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL1446083 0.95 KDR (0.81) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL1446086 0.95 KDR (0.81) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL4096274 0.94 EGFR (0.84) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL4523013 0.90 EGFR (0.77) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL13606789 0.90 EGFR (0.77) KDREPHB4ERBB2EPHA2EGFR
SCHEMBL4524312 0.90 EGFR (0.77) KDREPHB4ERBB2EPHA2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110840847-B Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases 沃泰克斯药物股份有限公司 2022-07-29 CN disclosed
CN-110713489-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-05-31 CN disclosed
CN-110183440-B Heteroaryl SYK inhibitors 勃林格殷格翰国际有限公司 2022-04-22 CN disclosed